Literature DB >> 18354180

Immunodominance in the TCR repertoire of a [corrected] TCR peptide-specific CD4+ Treg population that controls experimental autoimmune encephalomyelitis.

Loui Thomas Madakamutil1, Igor Maricic, Eli E Sercarz, Vipin Kumar.   

Abstract

Immunodominance in self-Ag-reactive pathogenic CD4(+) T cells has been well established in several experimental models. Although it is clear that regulatory lymphocytes (Treg) play a crucial role in the control of autoreactive cells, it is still not clear whether immunodominant CD4(+) Treg clones are also involved in control of autoreactivity. We have shown that TCR-peptide-reactive CD4(+) and CD8(+) Treg play an important role in the spontaneous recovery and resistance from reinduction of experimental autoimmune encephalomyelitis in B10.PL mice. We report, by sequencing of the TCR alpha- and beta-chain associated with CD4(+) Treg, that the TCR repertoire is limited and the majority of CD4(+) Treg use the TCR Vbeta14 and Valpha4 gene segments. Interestingly, sequencing and spectratyping data of cloned and polyclonal Treg populations revealed that a dominant public CD4(+) Treg clonotype expressing Vbeta14-Jbeta1.2 with a CDR3 length of 7 aa exists in the naive peripheral repertoire and is expanded during the course of recovery from experimental autoimmune encephalomyelitis. Furthermore, a higher frequency of CD4(+) Treg clones in the naive repertoire correlates with less severity and more rapid spontaneous recovery from disease in parental B10.PL or PL/J and (B10.PL x PL/J)F(1) mice. These findings suggest that unlike the Ag-nonspecific, diverse TCR repertoire among the CD25(+)CD4(+) Treg population, TCR-peptide-reactive CD4(+) Treg involved in negative feedback regulation of autoimmunity use a highly limited TCR V-gene repertoire. Thus, a selective set of immunodominant Treg as well as pathogenic T cell clones can be targeted for potential intervention in autoimmune disease conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18354180     DOI: 10.4049/jimmunol.180.7.4577

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid.

Authors:  Philomena Arrenberg; Ramesh Halder; Yang Dai; Igor Maricic; Vipin Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  CD4+CD25+Foxp3+ regulatory T cells optimize diversity of the conventional T cell repertoire during reconstitution from lymphopenia.

Authors:  Colleen J Winstead; Cavan S Reilly; James J Moon; Marc K Jenkins; Sara E Hamilton; Stephen C Jameson; Sing Sing Way; Alexander Khoruts
Journal:  J Immunol       Date:  2010-03-31       Impact factor: 5.422

3.  Preferential Use of Public TCR during Autoimmune Encephalomyelitis.

Authors:  Yunqian Zhao; Phuong Nguyen; Jing Ma; Tianhua Wu; Lindsay L Jones; Deqing Pei; Cheng Cheng; Terrence L Geiger
Journal:  J Immunol       Date:  2016-05-11       Impact factor: 5.422

4.  T cell receptors in an IL-10-secreting amino acid copolymer-specific regulatory T cell line that mediates bystander immunosuppression.

Authors:  Hong Zhang; Joel N H Stern; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-09       Impact factor: 11.205

5.  Genetically modified hematopoietic stem/progenitor cells that produce IL-10-secreting regulatory T cells.

Authors:  Sze-Ling Ng; Ester Leno-Duran; Dibyendu Samanta; Steven C Almo; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-25       Impact factor: 11.205

6.  Autoimmune susceptibility imposed by public TCRβ chains.

Authors:  Yunqian Zhao; Phuong Nguyen; Peter Vogel; Bofeng Li; Lindsay L Jones; Terrence L Geiger
Journal:  Sci Rep       Date:  2016-11-21       Impact factor: 4.379

Review 7.  Restoring immune tolerance in neuromyelitis optica: Part I.

Authors:  Larry Steinman; Amit Bar-Or; Jacinta M Behne; Daniel Benitez-Ribas; Peter S Chin; Michael Clare-Salzler; Donald Healey; James I Kim; David M Kranz; Andreas Lutterotti; Roland Martin; Sven Schippling; Pablo Villoslada; Cheng-Hong Wei; Howard L Weiner; Scott S Zamvil; Michael R Yeaman; Terry J Smith
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.